Repligen (RGEN) Net Cash Flow Growth (1y) (2011 - 2026)
Powered by 
Analysis
Repligen (RGEN) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | 498.33% |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | -260.86% |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | -189.36% |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | 73.12% |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 188.37% |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 576.28% |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | 103.25% |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 130.07% |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | -39.60% |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 137.77% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 130.07% |
| Mar 31, 2026 | 129.26% |
| Dec 31, 2025 | -657.53% |
| Sep 30, 2025 | 253.30% |
| Jun 30, 2025 | -63.34% |
| Mar 31, 2025 | -334.30% |
| Dec 31, 2024 | -118.96% |
| Sep 30, 2024 | -188.07% |
| Jun 30, 2024 | -67.93% |
| Mar 31, 2024 | 449.04% |
| Dec 31, 2023 | 313.21% |
| Sep 30, 2023 | 299.54% |
| Jun 30, 2023 | 425.78% |
| Mar 31, 2023 | 54.20% |
| Dec 31, 2022 | -380.48% |
| Sep 30, 2022 | 86.52% |
| Jun 30, 2022 | -17.25% |
| Mar 31, 2022 | -2,317.88% |
| Dec 31, 2021 | -107.99% |
| Sep 30, 2021 | -959.38% |